LITTLE FALLS, N.J.,
June 18, 2018 /PRNewswire/ -- Cantel
Medical Corp. (NYSE: CMD) today announced its entry into the dental
wastewater management market through the recent launch of
Syclone™ Amalgam Separator, previously marketed and
sold under the brand name, Apavia™ Amalgam Separator.
This new filtration technology and related assets were recently
acquired from ENPRESS L.L.C. and its subsidiary Apavia LLC.
Syclone™ Amalgam Separator captures
mercury-containing amalgam particles from the wastewater of dental
offices through a combination of mechanisms, including filtration
and centrifugation. In addition, it features a high containment
capacity for extended service and pump life, and cutting-edge
cyclonic design with rapid velocity and waste capture.
"As a market leader, we are committed to staying at the
forefront of the latest industry trends and to providing quality
solutions that meet the compliance needs of dental practices. With
the Syclone™ filtration technology, we can effectively
support the hundreds of thousands of dental practices in meeting
the requirement of removing mercury from wastewater and improving
the overall environment," stated Gary
Steinberg, President and CEO of Crosstex.
"We look forward to integrating the Syclone™
Amalgam Separator technology into our expanding portfolio of
solutions for infection prevention," stated Ken Plunkett, Senior Vice President Global
Sales, Crosstex. "Given the EPA ruling on amalgam separators for
wastewater management compliance by July
2020, the addition of this innovative technology further
enhances our dental water compliance products, beyond our
DentaPure™ Cartridge for dental water purification."
The Syclone™ Amalgam Separator will be available
for customers in the coming months. For more information, please
visit www.crosstex.com.
About Cantel Medical Corp.
Cantel Medical is a leading global company dedicated to delivering
innovative infection prevention and control products and services
for patients, caregivers, and other healthcare providers which
improve outcomes, enhance safety and help save lives. Our
products include specialized medical device reprocessing systems
for endoscopy and renal dialysis, advanced water purification
equipment, sterilants, disinfectants and cleaners, sterility
assurance monitoring products for hospitals and dental clinics,
disposable infection control products primarily for dental and GI
endoscopy markets, dialysate concentrates, hollow fiber membrane
filtration and separation products, and specialty packaging for
infectious and biological specimens. Additionally, we provide
technical service for our products.
For further information, visit the Cantel website at
www.cantelmedical.com.
About Crosstex International, Inc.
Crosstex, a Cantel
Medical company, manufactures a wide array of unique and innovative
infection prevention and compliance products for the global
healthcare industry. Founded in 1953 and headquartered in
Hauppauge, New York, Crosstex is a
recognized leader for its portfolio of waterline treatment,
biological monitoring, sterility assurance packaging and personal
protection equipment (PPE). Sold in more than 100 countries,
the range of products distributed to medical, dental and veterinary
practices and facilities include our award winning (5 consecutive
years) SECURE FIT™ Face Masks, DENTAPURE™ Waterline Treatment
Cartridges and Liquid Ultra™ Solution, SURE-CHECK™ Sterilization
Pouches with internal/external multi-parameter indicators, TYVEK™
Pouches with 510K approval,
STEAMPLUS™ Type 5 Chemical Integrators, CONFIRM™ Monitoring System
and PASSPORT™ Plus In-Office and Mail-In Biological Indicators,
RAPACIDE™ OPA/28 High Level Disinfectant, and AXESS™ and ClearView™
Nasal Masks for nitrous oxide/oxygen sedation.
For information on the full line of Crosstex infection
prevention, patient safety and compliance products, please contact
Crosstex at 631-582-6777 or visit
www.crosstex.com.
About Enpress, LLC
ENPRESS LLC is a worldwide
leading manufacturer of composite pressure vessels and filtration
systems for use in water treatment. The exclusive and patented
products designed by ENPRESS provide superior performance and
water saving solutions.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.
View original
content:http://www.prnewswire.com/news-releases/cantel-expands-its-dental-water-solutions-portfolio-with-entry-into-amalgam-separator-category-300667418.html
SOURCE Cantel Medical Corp.